Gómez-Herranz, M.; Faktor, J.; Yébenes Mayordomo, M.; Pilch, M.; Nekulova, M.; Hernychova, L.; Ball, K.L.; Vojtesek, B.; Hupp, T.R.; Kote, S.
Emergent Role of IFITM1/3 towards Splicing Factor (SRSF1) and Antigen-Presenting Molecule (HLA-B) in Cervical Cancer. Biomolecules 2022, 12, 1090.
https://doi.org/10.3390/biom12081090
AMA Style
Gómez-Herranz M, Faktor J, Yébenes Mayordomo M, Pilch M, Nekulova M, Hernychova L, Ball KL, Vojtesek B, Hupp TR, Kote S.
Emergent Role of IFITM1/3 towards Splicing Factor (SRSF1) and Antigen-Presenting Molecule (HLA-B) in Cervical Cancer. Biomolecules. 2022; 12(8):1090.
https://doi.org/10.3390/biom12081090
Chicago/Turabian Style
Gómez-Herranz, Maria, Jakub Faktor, Marcos Yébenes Mayordomo, Magdalena Pilch, Marta Nekulova, Lenka Hernychova, Kathryn L. Ball, Borivoj Vojtesek, Ted R. Hupp, and Sachin Kote.
2022. "Emergent Role of IFITM1/3 towards Splicing Factor (SRSF1) and Antigen-Presenting Molecule (HLA-B) in Cervical Cancer" Biomolecules 12, no. 8: 1090.
https://doi.org/10.3390/biom12081090
APA Style
Gómez-Herranz, M., Faktor, J., Yébenes Mayordomo, M., Pilch, M., Nekulova, M., Hernychova, L., Ball, K. L., Vojtesek, B., Hupp, T. R., & Kote, S.
(2022). Emergent Role of IFITM1/3 towards Splicing Factor (SRSF1) and Antigen-Presenting Molecule (HLA-B) in Cervical Cancer. Biomolecules, 12(8), 1090.
https://doi.org/10.3390/biom12081090
